Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Regional Health Properties | RHE | Nov 14, 2024 | 1.40 | +6.87 |
Regional Health Properties A Pref | RHE-A | Nov 14, 2024 | 0.45 | 0.00 |
Regional Management | RM | Nov 14, 2024 | 29.73 | +0.20 |
Regions Financial | RF | Nov 14, 2024 | 26.27 | +0.65 |
Regions Financial B Pref | RF-B | Nov 14, 2024 | 24.98 | 0.00 |
Regions Financial C Pref | RF-C | Nov 14, 2024 | 24.45 | -0.04 |
Regions Financial E Pref | RF-E | Nov 14, 2024 | 19.40 | +0.36 |
Regions Finl New Dep Shs Repstg 1100th Perp Pfd Ser F | RF-F | Nov 14, 2024 | 26.01 | +0.89 |
Regis | RGS | Nov 14, 2024 | 18.00 | +1.18 |
Regulus Therapeutics | RGLS | Nov 14, 2024 | 1.50 | 0.00 |
Reinsurance Group of America | RGA | Nov 14, 2024 | 229.51 | -0.37 |
REIT Index ETF Vanguard | VNQ | Nov 14, 2024 | 93.75 | -0.90 |
Reitar Logtech | RITR | Nov 14, 2024 | 4.49 | 0.00 |
Rekor Systems | REKR | Nov 14, 2024 | 1.08 | -5.26 |
Relay Therapeutics | RLAY | Nov 14, 2024 | 5.60 | -3.61 |
Reliance | RS | Nov 14, 2024 | 309.97 | -0.94 |
Reliance Global | RELI | Nov 14, 2024 | 1.59 | -11.17 |
Relmada Therapeutics | RLMD | Nov 14, 2024 | 3.16 | -1.56 |
RELX ADR | RELX | Nov 14, 2024 | 45.95 | -0.37 |
Remitly Global | RELY | Nov 14, 2024 | 19.83 | -2.07 |
Renaissance Ipo ETF | IPO | Nov 14, 2024 | 45.29 | -1.86 |
RenaissanceRe | RNR | Nov 14, 2024 | 256.96 | -1.27 |
RenaissanceRe G Pref | RNR-G | Nov 14, 2024 | 18.10 | +0.22 |
RenaissanceRe Holding F Pref | RNR-F | Nov 14, 2024 | 24.42 | +0.04 |
Renalytix ADR | RNLX | Nov 14, 2024 | 0.20 | 0.00 |
Renasant | RNST | Nov 14, 2024 | 36.75 | -0.70 |
Reneo Pharmaceuticals | RPHM | Nov 14, 2024 | 1.82 | 0.00 |
ReNew Energy Global A Shares | RNW | Nov 14, 2024 | 5.34 | +2.30 |
Renn Fund | RCG | Nov 14, 2024 | 2.37 | +1.72 |
Renovaro Biosciences | RENB | Nov 14, 2024 | 0.58 | -3.04 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.